Biometrics

• 

  Publication Venue For

  • Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data..  74:1180-1192. 2018
  • Sample size determination for GEE analyses of stepped wedge cluster randomized trials..  74:1450-1458. 2018
  • Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach..  74:900-909. 2018
  • PenPC: A two-step approach to estimate the skeletons of high-dimensional directed acyclic graphs..  72:146-155. 2016
  • Using decision lists to construct interpretable and parsimonious treatment regimes..  71:895-904. 2015
  • A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies..  71:529-537. 2015
  • Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records..  71:478-486. 2015
  • Discussion of "Combining biomarkers to optimize patient treatment recommendation"..  70:707-710. 2014
  • Evaluating marker-guided treatment selection strategies..  70:489-499. 2014
  • Assessing the causal effect of organ transplantation on the distribution of residual lifetime..  69:820-829. 2013
  • Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling..  69:830-839. 2013
  • A robust method for estimating optimal treatment regimes..  68:1010-1018. 2012
  • A moment-adjusted imputation method for measurement error models..  67:1461-1470. 2011
  • Insights on the robust variance estimator under recurrent-events model..  67:1564-1572. 2011
  • Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout..  67:536-545. 2011
  • A penalized likelihood approach for bivariate conditional normal models for dynamic co-expression analysis..  67:299-308. 2011
  • A generalized estimator of the attributable benefit of an optimal treatment regime..  66:512-522. 2010
  • Design and inference for cancer biomarker study with an outcome and auxiliary-dependent subsampling..  66:502-511. 2010
  • Regression on quantile residual life..  65:1203-1212. 2009
  • Shrinkage-based diagonal discriminant analysis and its applications in high-dimensional data..  65:1021-1029. 2009
  • Bayesian inference for smoking cessation with a latent cure state..  65:970-978. 2009
  • Gene-trait similarity regression for multimarker-based association analysis..  65:822-832. 2009
  • Latent-model robustness in joint models for a primary endpoint and a longitudinal process..  65:719-727. 2009
  • Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials..  64:1247-1255. 2008
  • Improving efficiency of inferences in randomized clinical trials using auxiliary covariates..  64:707-715. 2008
  • "Smooth" semiparametric regression analysis for arbitrarily censored time-to-event data..  64:567-576. 2008